We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.06B
1-Year Est. Return 24.93%
This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
AUM
$1B
AUM Growth
+$97.1M
Cap. Flow
-$4.15M
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.81%
Holding
263
New
1
Increased
Reduced
258
Closed
2

Top Buys

Rank Stock Value
1
FNF icon
Fidelity National Financial
FNF
+$970K

Sector Composition

Rank Sector Weight
1 Technology 36.81%
2 Financials 16.65%
3 Healthcare 12.19%
4 Communication Services 9.17%
5 Consumer Discretionary 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
51
Chubb
CB
$140B
$5.33M 0.53%
20,484
-64
-0.3% -$15.7K
ADP icon
52
Automatic Data Processing
ADP
$100B
$5.26M 0.53%
20,940
-65
-0.3% -$15.9K
NDAQ icon
53
Nasdaq
NDAQ
$52.1B
$5.03M 0.5%
79,716
-248
-0.3% -$14.3K
BAC icon
54
Bank of America
BAC
$435B
$5.01M 0.5%
132,019
-412
-0.3% -$14.1K
CI icon
55
Cigna
CI
$76.6B
$4.98M 0.5%
13,702
-43
-0.3% -$14.2K
TT icon
56
Trane Technologies
TT
$106B
$4.79M 0.48%
15,967
-50
-0.3% -$13.6K
CMI icon
57
Cummins
CMI
$91.7B
$4.64M 0.46%
15,749
-49
-0.3% -$12.6K
AVGO icon
58
Broadcom
AVGO
$1.82T
$4.62M 0.46%
34,820
-110
-0.3% -$13.6K
IBM icon
59
IBM
IBM
$202B
$4.56M 0.46%
23,894
-74
-0.3% -$13.5K
C icon
60
Citigroup
C
$222B
$4.52M 0.45%
71,432
-223
-0.3% -$12.4K
ORCL icon
61
Oracle
ORCL
$331B
$4.45M 0.44%
35,426
-110
-0.3% -$12.6K
WST icon
62
West Pharmaceutical
WST
$23.1B
$4.4M 0.44%
11,113
-35
-0.3% -$12.9K
CDNS icon
63
Cadence Design Systems
CDNS
$90B
$4.31M 0.43%
13,842
-43
-0.3% -$12.7K
STT icon
64
State Street
STT
$50.9B
$4.31M 0.43%
55,213
-172
-0.3% -$12.8K
TMO icon
65
Thermo Fisher Scientific
TMO
$211B
$4.27M 0.43%
7,348
-23
-0.3% -$12.9K
HIG icon
66
Hartford Financial Services
HIG
$38.5B
$4.25M 0.42%
41,043
-128
-0.3% -$11.7K
BMY icon
67
Bristol-Myers Squibb
BMY
$127B
$4.24M 0.42%
78,123
-244
-0.3% -$12.4K
VRTX icon
68
Vertex Pharmaceuticals
VRTX
$121B
$4.22M 0.42%
10,094
-31
-0.3% -$13.1K
MKC icon
69
McCormick & Company Non-Voting
MKC
$13.4B
$4.16M 0.42%
54,130
-169
-0.3% -$11.5K
FERG icon
70
Ferguson
FERG
$44.7B
$4.1M 0.41%
18,688
-58
-0.3% -$11.6K
COF icon
71
Capital One
COF
$124B
$3.98M 0.4%
26,733
-83
-0.3% -$11.2K
PLD icon
72
Prologis
PLD
$138B
$3.96M 0.4%
30,441
-95
-0.3% -$12.4K
MMM icon
73
3M
MMM
$89B
$3.62M 0.36%
40,774
-127
-0.3% -$10.5K
CLX icon
74
Clorox
CLX
$11.6B
$3.61M 0.36%
23,553
-73
-0.3% -$10.9K
TROW icon
75
T. Rowe Price
TROW
$25B
$3.6M 0.36%
29,501
-92
-0.3% -$10.3K

Similar funds

Kintegral Advisory's Q1 2024 Portfolio in Review

As of Q1 2024, Kintegral Advisory held 263 positions worth $1B, up 11% from $903M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 1.1%. Kintegral Advisory opened 1 new position and exited 2, leaving the 263-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • Kintegral Advisory's largest Q1 2024 buy was Fidelity National Financial: 19,247 shares worth $1.43M.
  • Kintegral Advisory's biggest Q1 2024 reduction was Microsoft, cutting an estimated $260K.
  • Kintegral Advisory fully exited Fidelity National Information Services in Q1 2024, selling an estimated $1.16M.
  • Kintegral Advisory's ten largest holdings make up 34% of its $1B portfolio in Q1 2024.
  • Kintegral Advisory opened 1 new position and closed 2 in Q1 2024.
  • Kintegral Advisory's portfolio value rose 11% quarter-over-quarter to $1B.

Based on Kintegral Advisory's 13F filing for Q1 2024, filed 25 Apr 2024.